Maven Securities LTD - VERTEX PHARMACEUTICALS INC ownership

VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F950. A total of 6 filers reported holding VERTEX PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Maven Securities LTD ownership history of VERTEX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,877,796
+695.7%
5,400
+315.4%
0.02%
+162.5%
Q3 2021$236,000
-2.5%
1,300
+8.3%
0.01%
-20.0%
Q2 2021$242,000
-69.6%
1,200
-67.6%
0.01%
-72.2%
Q1 2021$795,000
-63.6%
3,700
-53.8%
0.04%
-80.0%
Q3 2020$2,187,000
+47.7%
8,000
+56.9%
0.18%
+78.2%
Q2 2020$1,481,000
+314.8%
5,100
+240.0%
0.10%
+140.5%
Q1 2020$357,000
+64.5%
1,500
+50.0%
0.04%
+110.0%
Q4 2019$217,0001,0000.02%
Other shareholders
VERTEX PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 30,100$10,466,9740.04%
SIMPLEX TRADING, LLC 82,500$28,6880.02%
Maven Securities LTD 5,400$1,877,7960.02%
Allianz Asset Management GmbH 25,400$8,832,5960.02%
IMC-Chicago, LLC 41,300$14,361,6620.01%
JANE STREET GROUP, LLC 73,300$25,489,3420.01%
JPMORGAN CHASE & CO 49,300$17,143,5820.00%
SG Americas Securities, LLC 15,000$930.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of VERTEX PHARMACEUTICALS INC shareholders